Emyria

EMD.AX

Tags: AU Healthcare Medical - Healthcare Information Services

Emyria Limited Price (EMD.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

358,968,879

(24.0447)%

Market Cap of Emyria (EMD.AX)

Market cap:

As of , EMD.AX has a market cap of . This makes EMD.AX the 1181th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Austr... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.0265-0.07
Market Cap 15.27M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Healthcare Information Services

ceo: Mr. Gregory Hutchinson
IPO Date: February, 11, 2020
Country: AU
Currency: AUD
Headquaters: Leederville, WA
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: